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A microRNA cluster in the Fragile-X region
expressed during spermatogenesis targets FMR1
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Abstract
Testis-expressed X-linked genes typically evolve rapidly. Here, we
report on a testis-expressed X-linked microRNA (miRNA) cluster
that despite rapid alterations in sequence has retained its position
in the Fragile-X region of the X chromosome in placental
mammals. Surprisingly, the miRNAs encoded by this cluster (Fx-
mir) have a predilection for targeting the immediately adjacent
gene, Fmr1, an unexpected finding given that miRNAs usually act
in trans, not in cis. Robust repression of Fmr1 is conferred by
combinations of Fx-mir miRNAs induced in Sertoli cells (SCs) during
postnatal development when they terminate proliferation. Physio-
logical significance is suggested by the finding that FMRP, the
protein product of Fmr1, is downregulated when Fx-mir miRNAs
are induced, and that FMRP loss causes SC hyperproliferation and
spermatogenic defects. Fx-mir miRNAs not only regulate the
expression of FMRP, but also regulate the expression of eIF4E and
CYFIP1, which together with FMRP form a translational regulatory
complex. Our results support a model in which Fx-mir family
members act cooperatively to regulate the translation of batteries
of mRNAs in a developmentally regulated manner in SCs.
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Introduction
Conventional wisdom holds that conserved genes are critical for
biological processes. However, an emerging area of interest is
rapidly diverging genes, as these have the potential to confer
species-specific traits while simultaneously retaining ancient func-
tions [1,2]. Testes-expressed genes are a particularly rich source of
genes undergoing rapid evolution [3,4]. While the underlying mech-
anism is not known, evidence suggests that strong selection pres-
sures—including post-copulatory sexual selection mechanisms (e.g.,
sperm competition)—drive the rapid sequence alterations in testes-
expressed genes [5–9]. Particularly enriched for rapidly evolving
genes is the mammalian X chromosome, in part, because it is single
copy in males and thus can allow for rapid fixation of sequence
alterations that confer a selective advantage in spermatogenesis and
other male-associated functions [10–14].
In this communication, we investigate the evolution, expression,
and function of an X-linked microRNA (miRNA) cluster. miRNAs
are small (~22 nt) RNAs that regulate gene expression through
translational repression or destabilization of their target transcripts
[15–17]. Mammalian genomes encode hundreds of miRNAs, many
of which are spatially and temporally regulated [18]. In turn, each
miRNA can potentially target hundreds of mRNAs [19]. miRNAs
have important functions in many aspects of cellular differentiation
and homeostasis, and consequently have roles in many pathologies,
including cancer, neural disease, and infertility [20–22]. About 40%
of microRNAs are estimated to form clusters whose physiological
importance is largely unknown [23]. In contrast, the roles of indi-
vidual miRNAs have been defined in a variety of physiological and
pathological states [24,25].
In this report, we report the discovery of a miRNA cluster in the
Fragile-X region of the X chromosome with unusual functional qual-
ities that has undergone rapid evolution in placental mammals. The
miRNAs encoded by this cluster are primarily expressed in the
testis, thereby providing an explanation for their rapid evolution.
Given that miRNAs act in trans, not in cis, we were surprised to find
that a large number of the miRNAs in this Fragile-X cluster target
the immediately adjacent gene: FMR1. Indeed, the position of this
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miRNA cluster next to FMR1 is evolutionarily conserved in
placental mammals. Given that FMR1 encodes a translational
regulator [26], we examined the role of members of this Fragile-X
miRNA cluster in regulating translation, as well as the biological
contexts in which it acts. Our findings have implications for
evolution, spermatogenesis, and the diagnosis and treatment of
male infertility.
Results
Fx-mir—a rapidly evolving miRNA cluster directly adjacent
to Fmr1
Our long-term interest in miRNAs, X-linked gene clusters, and
intellectual disability [27–31] led us to note the existence of a
large group of miRNAs in the Fragile-X region of the mouse X
chromosome (Fig 1A). The Fragile-X region is best known for
housing the FMR1 gene, which when mutated, causes Fragile-X
Syndrome (FXS), the most common form of inherited intellectual
disability in humans [32–34]. The Fragile-X region also harbors
several other protein-coding genes that have been given the
“Fragile X” designation (Appendix Fig S1A). Thus, we elected to
name the miRNA cluster in this region the “Fragile-X miRNA (Fx-
mir)” cluster. There are no annotated protein-coding genes inter-
rupting the miRNA genes in the mouse Fx-mir cluster. All 22
miRNAs in this cluster are oriented in the same direction, raising
the possibility that these miRNAs could all be derived from a
single transcription unit.
To gain insight into the evolutionary origins of this cluster, we
mapped the Fx-mir cluster in multiple species, based on available
Ensembl assemblies. We examined three placental mammals
[human (Homo sapien), dog (Canis familiaris), and elephant (Loxo-
donta africana)] in addition to mice and observed that all four of
these mammalian species have a miRNA cluster between the Fmr1
and Slitrk2 protein-coding genes (Fig EV1). In contrast, no observ-
able miRNA cluster is present in the non-placental mammal opos-
sum (Monodelphis domestica) (Fig EV1). Although the Slitrk2 gene
appears to be specific to placental mammals, a broader syntenic
analysis shows that the linear relationship between Fmr1 and two
upstream markers, Fam122b and the miR-18b miRNA cluster, is
retained in all five species we examined, including opossum,
thereby allowing us to unambiguously conclude that opossum lacks
the Fx-mir cluster, at least at its chromosomal location in placental
mammals. Together, our results indicate that the Fx-mir cluster is
present at a conserved location in the Fragile-X region of placental
mammals.
Because the human and mouse genomes are well annotated, we
focused our subsequent analysis on the Fx-mir cluster in these two
species. Both the mouse Fx-mir and human FX-MIR clusters consist
of the same number of miRNAs (Figs 1A and B). Furthermore, all
the miRNA genes are oriented in the same transcriptional direction
in both the mouse and human clusters. In striking contrast to these
conserved features, only one miRNA encoded by these clusters has
retained sufficient sequence similarity in mice and humans to be
clearly defined as an ortholog (Fig 1). This miRNA, miR-509,
displayed considerable sequence identity between both mouse and
humans throughout the length of its precursor (Appendix Fig S1B).
Furthermore, most of the seed sequence in mature miR-509 is iden-
tical between mice and humans. To screen for other candidate
orthologous miRNAs within this cluster, we aligned each of the 22
mouse Fx-mir miRNA precursor sequence with each of the 22
human FX-MIR precursor sequences (data not shown). This analy-
sis revealed considerable sequence identity between the precursor
sequences of mouse miR-881 and human miR-892a, as well as
between mouse miR-880 and both human miR-888 and miR-890
(Appendix Fig S1C). However, there is only limited sequence iden-
tity in the seed region, precluding defining these miRNAs as being
definitive orthologs.
Mouse Fx-mir cluster family members target Fmr1
Using several miRNA target prediction programs, we noted that a
frequent putative direct target of several members of the mouse Fx-
mir cluster is Fmr1, the directly adjacent gene (Fig 1A). To system-
atically test the possibility that Fx-mir family members have a
predilection for targeting Fmr1, we first performed an in silico
screen to identify all miRNAs predicted to regulate Fmr1. We used
two target prediction programs—TargetScan and microRNA.org—to
increase the probability of identifying bona fide targets. Both
conserved and non-conserved miRNAs were considered using the
miRanda target sites and mirSVR scores provided by microRNA.org
[35]. Appendix Table S1 lists the 15 miRNAs with the highest
prediction scores of the 1,915 candidate mouse miRNAs in miRBase
that were analyzed. Two of the top 15 miRNAs predicted to
target Fmr1 are encoded by Fx-mir cluster. One of these two
miRNAs, miR-743b-3p, has the second highest prediction score
(Appendix Table S1). We next extended our in silico analysis to
screen all miRNAs predicted to target Fmr1 and found that 15
miRNAs in the Fx-mir cluster are predicted to target Fmr1.
Table EV1 provides a list of “high-confidence” miRNAs that had a
mirSVR score of < 0.5 (indicated in blue); a number of these were
also predicted by the TargetScan algorithm (Table EV1). Some of
these high-confidence miRNAs target more than one site, bringing
the total number of predicted Fx-mir-binding sites in the Fmr1 30UTR
to 21.
To address whether the Fx-mir cluster has more of a propensity
to target Fmr1 than other testes-expressed genes, we compared the
number of predicted Fx-mir-binding sites in the 30UTR of Fmr1 to
the 30UTR from other genes expressed in testes (Table EV2). This
analysis revealed that the Fmr1 30UTR had more predicted target
sites than did the 30UTRs of other randomly chosen genes
(Table EV2), four of which (Ar, Vegf, Dazl, and Foxi1) we empiri-
cally showed through reporter analysis are targeted by at least one
Fx-mir family member. To more systematically address this ques-
tion, we took advantage of a recent study identifying genes exhibit-
ing enriched expression in Sertoli cells (SCs) [36], the primary
testicular cell type that expresses several Fx-mir family members
(see below). These ~500 SC-enriched genes were identified by
RiboTag analysis of testes specifically expressing a tagged ribosomal
subunit in SCs [36]. We asked which of these ~500 SC-enriched
genes are targeted by Fx-mir family members by mining target site
predictions (microRNA.org), using a mirSVR score of < 0.5. This
analysis revealed that Fmr1 had more predicted Fx-mir target sites
than any of the other SC-enriched genes (Fig 2A [red line] and
Appendix Table S2), and supports the hypothesis that the Fx-mir
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cluster has a strong predilection for targeting the neighboring gene,
Fmr1.
To empirically test whether Fx-mir family members target Fmr1,
we first employed reporter analysis. The full-length 30UTR of Fmr1
was cloned into a firefly luciferase reporter vector, and this reporter
was co-transfected into the P19 mouse teratocarcinoma cell line [37]
with selected Fx-mir miRNA precursors. This analysis identified 6
Fx-mir family members that downregulated Fmr1 30UTR-driven
reporter expression (Fig 2B; of note, miRNAs without a 5p/3p
designation are from the 5p strand). The reduction in reporter
expression was consistent with the known action of most miRNAs,
which suppress their targets [38,39]. Downregulation of FMRP by
Fx-mir family members was also confirmed at the protein level by
Western blot analysis (Figs 2C and EV2A).
Given that several Fx-mir family members are primarily
expressed in SCs (see below), we examined the effect of selected Fx-
mir miRNAs in MSC1, an established Sertoli cell line that has been
used extensively in previous studies to analyze gene regulation in
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Figure 1. The mouse and human Fx-mir (FX-MIR) cluster.
A, B For each panel, left shows the location of Fx-mir cluster (A) or FX-MIR cluster (B) on the X chromosome relative to neighboring genes. The numbers in purple
represent the chromosomal position of the genes while the numbers in brown indicate intergenic distances. Right shows the relative position of Fx-mir/FX-MIR
family members, drawn to scale, except when indicated. The arrowheads indicate the transcriptional direction of the genes.
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SCs [27,40,41]. MSC1 cells do not express Fx-mir family members
(Fig EV2B), consistent with the fact that several SC-enriched genes
are turned off when SCs are established in culture [42,43]. However,
the MSC1 cell line maintains many characteristics of SCs [42,44],
and its low/undetectable expression of Fx-mir miRNAs allowed us
to take a gain-of-function approach to analyze the function of Fx-mir
miRNAs in SCs. Transfection analysis in MSC1 cells revealed that
several of the miRNAs we tested downregulated Fmr1 30UTR-driven
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reporter expression (Fig 2D). However, two of the miRNAs that
repressed Fmr1 reporter expression in P19 cells—miR-881 and miR-
465a (Fig 2B)—did not have a significant effect when force
expressed in MSC1 cells (Fig 2D). This is not because MSC1 cells
express endogenous miR-881 and miR-465a; indeed, neither MSC1
nor P19 cells express detectable levels of these miRNAs (Fig EV2C
and D). Transfection of miR-881 and miR-465a precursors generated
levels of these miRNAs in MSC1 cells similar to that of a Fx-mir
family member (miR-878) that does downregulate the Fmr1 reporter
(Figs 2D and EV2D), indicating that the lack of effect of miR-881
and miR-465a on the reporter in MSC1 cells is not due to low
expression. The explanation we favor is that cell type-specific
factors are responsible for the differential activity of these miRNAs
in P19 and MSC1 cells. As precedence for this, a recent study identi-
fied tissue-specific miRNA-silencing complexes [45].
Figure EV3A shows the high-confidence binding sites for Fx-mir
family members predicted to target the Fmr1 30UTR. While these
predicted binding sites lie throughout the length of the Fmr1 30UTR,
they tend to be clustered in three regions. The specific sequences of
some of these predicted binding sites and their complementarity
with specific Fx-mir miRNAs are shown in Fig EV3B. To test their
functionality, we mutated the candidate miRNA-binding sites for
three miRNAs in the Fx-mir cluster that downregulated Fmr1 30UTR-
mediated reporter expression in both MSC1 and P19 cells (Figs 2B
and D). All eight nucleotides complementary with the miRNA seed
region and beyond were mutated (two in a given mutant construct)
to fully analyze the contribution of the seed complementarity
region. Figure 2E and F show the data for miR-878 and miR-880-3p,
both of which have only one strong predicted binding site in Fmr1
30UTR. Gain-of-function studies with their respective miRNA precur-
sors showed that 3 of the 4 miR-878 mutants had a statistically
significant reduction in miRNA-mediated repression of reporter
activity. The M3 and M2 mutants exhibited an almost complete loss
of repression in response to the miR-878 and miR-880-3p precursors,
respectively. Together, this provided strong evidence that miR-878
and miR-880-3p directly target Fmr1. miR-743b-3p has three
predicted binding sites in the Fmr1 30UTR (Fig EV3A); we made
several mutations in the two predicted binding sites with stronger
prediction scores [named “264 nt” and “1,482 nt”, based on their
position within the 30UTR (Table EV1)]. None of these mutants
strongly reduced responsiveness to miR-743b-3p (Fig EV3C), raising
the possibility that these two sites act redundantly. To test this, we
generated a 264/1,482 double mutant and found it almost comple-
tely lost its ability to respond to miR-743b-3p (Fig 2G). This indi-
cated that miR-743b-3p acts through two partially redundant
binding sites in the Fmr1 30UTR to repress Fmr1 expression.
We next took a loss-of-function approach to validate that Fx-mir
family members regulate Fmr1. We screened for cell lines that
express Fx-mir family members and found that most cell lines
lacked detectable expression (data not shown). The one exception
was germline stem (GS) cells (Fig EV3D), a spermatogonial stem
cell line that retains stem cell potential [46]. Using miRNA
competitors, we repressed Fx-mir family members we found were
expressed in GS cells. Reporter analysis revealed that repression of
miR-465a and miR-743b-3p elevated the expression of the Fmr1-
driven reporter (Fig 2H), confirming our gain-of-function evidence
that these miRNAs target Fmr1 (Figs 2B–D). In contrast, Fmr1-
driven reporter expression was not significantly affected by repres-
sion of miR-878 and miR-880-3p, perhaps because these miRNAs
can act redundantly as suggested by our miRNA mixing experi-
ments shown below. We did not perform further experiments with
GS cells as they exhibit inefficient transfection efficiency (data not
shown) [47].
Mouse Fx-mir miRNAs exhibit developmentally regulated
expression in SCs
In what biological context does the Fx-mir cluster function to regu-
late Fmr1? It has been previously shown that many of the miRNAs
in the Fx-mir cluster exhibit a testis-preferential or testis-specific
expression pattern [48–50]. To examine their expression pattern in
more detail, we chose to focus on four Fx-mir family members
targeting Fmr1. Three of these miRNAs (miR-743b-3p, miR-878, and
miR-880-3p) have the highest prediction scores for targeting Fmr1 of
all Fx-mir family members (Table EV1) and the fourth miRNA (miR-
741-3p) exhibited strong down-regulation of an Fmr1 30UTR reporter
(Fig 2B), despite having a low prediction score (Table EV1). We
found that all four of these miRNAs are most highly expressed in
the testis (Fig 3A), confirming previous reports [51,52]. These
miRNAs were also expressed in the epididymis (the organ where
sperm mature and are stored), but at ~10-fold lower level than in
the testis (Fig 3A). We also tested members of the rat Fx-mir cluster
and found they also exhibited testes-enriched expression
(Fig EV4A).
◀ Figure 2. Mouse Fx-mir family members directly regulate Fmr1.A Number of Fx-mir predicted binding sites in mouse SC-enriched genes. The Y-axis shows the number of binding sites predicted from microRNA.org target site
predictions, and the X-axis shows the number of genes targeted with 0–10 sites. The red line is Fmr1.
B–D Luciferase analysis of P19 cells (panel B) and MSC1 cells (panel D) co-transfected with the pMIR-luciferase reporter harboring the mouse Fmr1 30UTR and the
indicated Fx-mir miRNA precursors. A Renilla luciferase vector was co-transfected to normalize for transfection efficiency. The luciferase activity of cells transfected
with a negative-control scrambled precursor is set to 1. (C) Western blot analysis of endogenous FMRP protein levels in P19 cells transfected with respective Fx-mir
miRNAs or a negative-control miRNA precursor. The bottom panel shows mean FMRP levels relative to the internal control (GAPDH).
E–G Luciferase analysis of MSC1 cells co-transfected with (i) a miRNA precursor or a negative-control scrambled miRNA precursor and (ii) the pMIR-luciferase reporter
with the wild-type version of the mouse Fmr1 30UTR or mutant versions with the indicated predicted miRNA-binding site (bs) mutations. The seed sequences are
depicted in red and the mutations are in blue. miR-878 (panel E) and miR-880 (panel F) have one major predicted binding sites, while miR-743b-3p (panel G) has
three predicted binding sites, two of which were mutated, as described in the text. A Renilla luciferase vector was co-transfected to normalize for transfection
efficiency.
H Luciferase analysis of GS cells co-transfected with the pMIR-luciferase reporter harboring the mouse Fmr1 30UTR and the indicated Fx-mir miRNA competitors. The
luciferase activity of cells transfected with a negative-control scrambled competitor is set to 1.
Data information: In (B–H), the bars in the histogram represent three independent biological replicates. Data are presented as mean  SEM. *P < 0.05 (Student’s t-test).
Source data are available online for this figure.
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The testes-enriched expression of members of the Fx-mir cluster
raises the possibility it regulates Fmr1 in this organ. Consistent with
this possibility, FXS patients lacking FMR1 expression have macro-
orchidism and defects in spermatogenesis [53,54]. These defects are
recapitulated in Fmr1-null mice [55]. While the underlying cellular
mechanism for the generation of large testes is not known, a likely
possibility is SC over-expansion, based on finding that Fmr1-null
mice have hyper-proliferative SCs [56]. Also consistent with this
possibility is the finding that the protein product of Fmr1—FMRP—
is highly expressed in SCs in both mice and humans [57,58]. Thus,
in order for Fx-mir family members to regulate Fmr1 in a physiologi-
cal context, it is critical that these miRNAs are also expressed in
SCs. To assess this, we used two approaches. First, we assayed their
expression in germ cell-deficient mice. If they are primarily
expressed in SCs, their testicular expression should be increased in
these mice, as somatic cells are enriched in germ cell-deficient
testes. Indeed, 3 of 4 of the Fx-mir miRNAs we tested exhibited
elevated expression in germ cell-deficient testes relative to control
testes (Figs 3B and EV4B). Second, we purified enriched SCs and
found that they expressed high levels of Fx-mir miRNAs (Figs 3C
and EV4C). Three of the 4 miRNAs are expressed at higher levels in
purified SCs than total testis, indicating that SCs are the primary site
of their expression. We note that it has been previously reported
that Fx-mir miRNAs are expressed in germ cell-enriched fractions
[48,52,59], a finding we reproduced, but we found that expression
in the germ cell fractions was much lower than in the total testis
fraction (Fig EV4D). Whether this low signal represents trace Fx-mir
expression in germ cells or contamination of the germ cell fraction
with Fx-mir-expressing SCs remains to be determined.
SCs are nurse cells in contact with all stages of germ cells and
are critical for virtually all phases of spermatogenesis [60,61]. SCs
undergo a series of programmed events during the first wave of
spermatogenesis; thus, we next examined the expression of Fx-mir
miRNAs during this developmental time window (Fig 3D). We
found that all 4 mRNAs we tested are expressed at low level at P5,
when both SCs and germ cells are undergoing rapid proliferation.
Their expression dramatically elevates at later time points (Fig 3D),
coincident with a drop in FMRP protein expression (Fig 3E). miR-
741-3p and miR-880-3p reach their highest expression at P15, a time
point that coincides with the cessation of SC proliferation and the
initiation of SC terminal maturation [62,63]. Thus, these two
miRNAs are candidates to regulate the expression of mRNAs impor-
tant for this proliferation-to-maturation transition phase of SC devel-
opment. This possibility is particularly enticing given that SCs are
known to undergo hyperproliferation in Fmr1-null mice [56]. miR-
743b-3p and miR-878 exhibited peak expression slightly later, at
P20, when SCs undergo further maturation and germ cells initiate
differentiation by forming round spermatids. Given that germ cells
are in direct contact with SCs [64], this supports a model in which
miR-743b-3p and miR-878 regulate gene expression in SCs to influ-
ence germ cell differentiation. In support of the possibility that the
Fx-mir cluster is important for spermatogenesis, a recent study
reported that several human FX-MIR family members—including
miR-891b, miR-892b, miR-892a, miR-888, and miR-890—are dysreg-
ulated in men with asthenozoospermia [65].
Mouse Fx-mir miRNAs act additively to repress Fmr1 expression
miRNAs typically downregulate their mRNA targets by only
~20–40% [66]. To amplify their regulatory effect, several miRNAs
must work in conjunction to strongly downregulate a given target
mRNA. Our finding that several Fx-mir family members that target
Fmr1 30UTR (Fig EV3A) are co-expressed in SCs during the same
developmental window (Figs 3C and D) raised the possibility that
they work together to strongly regulate Fmr1. To test this hypothe-
sis, we examined whether combinations of Fx-mir family members
have greater effects than do single-family members. In support, we
found that several Fx-mir miRNAs had additive effects (Figs 3F and
G). Of note, an additive effect was observed even though we treated
the cells with only a half-dose (6.7 pmol) of each miRNA when
provided in combination, as compared to the full dose (13.4 pmol)
when provided singly (Fig 3F). Given that miR-878, miR-743b-3p,
and miR-880 all exhibited additive effects in various combinations
(Fig 3G), we also tested a combination of all three of these miRNAs
and found that this elicited a very strong repression (~80%) that
was much more pronounced than elicited by the individual miRNAs
(Fig 3H).
Mouse Fx-mir miRNAs regulate the FMRP-eIF4E-CYFIP1
translational regulatory complex
Having demonstrated that Fx-mir family members downregulate
Fmr1 expression, we next asked whether Fx-mir family members can
affect Fmr1 function. Given that the protein product of Fmr1, FMRP,
is a translation repressor, we examined whether Fx-mir miRNAs
affect this function. We chose to examine the FMRP-regulated gene,
interferon regulatory factor 1 (Irf1), as it encodes a protein involved
in spermatogenesis: It promotes germ cell survival in vitro and
◀ Figure 3. Developmentally regulated expression and additive action of mouse Fx-mir family members.A The steady-state levels of Fx-mir miRNAs in the indicated adult mouse tissues, as assessed by TaqMan-qPCR analysis. U6 levels were used to normalize miRNA
values.
B TaqMan-qPCR analysis of testes from three jsd mice and three control littermate mice. U6 snRNA levels were used for normalization.
C Fx-mir miRNA levels in total mouse testis and different testicular cell fractions assessed by TaqMan-qPCR analysis. U6 snRNA levels were used for normalization.
D TaqMan-qPCR analysis of testes from the indicated postnatal time points (n = 3 for each time point). U6 levels were used to normalize miRNA values.
E Western blot analysis of mice testes from the indicated postnatal time points.
F–H Luciferase analysis of MSC1 cells co-transfected with the pMIR-luciferase reporter harboring the mouse Fmr1 30UTR and the indicated Fx-mir miRNAs (n = 3). The
luciferase activity of cells transfected with a negative-control scrambled precursor is set to 1. A Renilla luciferase vector was co-transfected to normalize for
transfection efficiency.
Data information: In (B–D and F–H), the bars in the histogram represent three independent biological replicates. Data are presented as mean  SEM. *P < 0.05
(Student’s t-test).
Source data are available online for this figure.
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in vivo, and functions as a pro-mitogenic factor in spermatogonia
[67]. Transfection analysis showed that forced expression of a pool
of three Fx-mir miRNAs downregulated FMRP protein level and
increased IRF1 protein level (Fig 4A). Irf1 mRNA level was not
significantly altered by this treatment (Fig EV5A), consistent with
FMRP acting as a translational repressor [67]. The upregulation of
IRF1 was reversed by FMRP overexpression (Fig 4A). Taken
together, these data suggest that Fx-mir family members regulate
FMRP levels, which, in turn, allow them to regulate FMRP function.
Given that FMRP translationally regulates hundreds of mRNAs
[32–34], we hypothesized that Fx-mir family members influence
translation globally. To test this hypothesis, we used SUnSET, a
nonradioactive puromycin end-labeling assay that quantifies global
protein synthesis [68]. Using this approach, we found that forced
expression of miR-743b-3p significantly decreased protein synthesis
(Fig 4B). Two lines of evidence argue against this being the result of
cellular toxicity. First, P19 viable cell count and morphology were
not significantly affected by forced miR-743b-3p expression (data
not shown). Second, transfection of neither a related miRNA (miR-
743a-3p), nor a scramble-sequence negative-control miRNA, signifi-
cantly affected global translation (Fig 4B). As an independent
approach to assess the effect of miR-743b-3p on translation, we used
Click-iT metabolic labeling, which labels newly synthesized proteins
with the methionine analog, L-azidohomoalanine (AHA). This anal-
ysis verified that miR-743b-3p significantly represses translation
(Fig EV5B). While the effect of miR-743b-3p on global translation
rate was relatively modest (~20%), it has the potential to be physio-
logically relevant, as the translation rate of large batteries of mRNAs
would presumably be affected. If, instead, miR-743b-3p exerted
strong translational silencing, this would be expected to instead
cause toxicity, as does strong translational silencing during viral
infections [69].
In neurons, FMRP regulates translation through forming a transla-
tional regulatory complex with two other proteins: eIF4E and CYFIP1
[70]. eIF4E is a rate-limiting translation initiation factor essential for
translation, while CYFIP1 is an eIF4E-binding protein that represses
translation [70,71]. To test whether this complex exists in the testis,
we performed co-immunoprecipitation experiments. In support, we
found both FMRP and CYFIP1 were immunoprecipitated from testes
extracts by an eIF4E antibody but not control IgG or no antibody
(Fig 4C). We conclude that FMRP, eIF4E, and CYFIP1 interact
together in the testes just as they do in neurons.
In silico analysis showed that the 30UTR regions of Eif4e and
Cyfip1 are predicted to be targeted by several Fx-mir family
members (Table EV3), and thus, we next tested whether Fx-mir
miRNAs regulate eIF4E and CYFIP1. After cloning their full-length
30UTRs into the pMIR-luciferase vector, we performed transfection
analysis in MSC1 Sertoli cells and found that luciferase activity from
the reporter harboring either the Eif4e 30UTR or Cyfip1 30UTR was
repressed by several Fx-mir family members (Fig 4D and E). As
negative controls, we tested miRNAs not predicted to target these
two 30UTRs and found that, indeed, they had no significant effects
(Fig 4D and E). Analogous experiments performed in P19 cells
revealed similar effects as in MSC1 cells (Fig EV5C and D), suggest-
ing that these miRNAs have a broad ability to regulate Eif4e and
Cyfip1. Mutagenesis of the miR-743b-3p and miR-878 predicted bind-
ing sites in the mouse Eif4e 30UTR relieved miRNA-mediated repres-
sion (Fig 4F). Many mutants exerted statistically significant effects,
while others exerted a trend toward relieved repression. The same
was observed for the miR-743b-3p predicted binding site in the
Cyfip1 30UTR (Fig 4G). We conclude that some Fx-mir family
members directly target not only Fmr1, but also Eif4e and Cyfip1.
This finding, coupled with the expression pattern of these miRNAs
in SCs, supports a model in which specific Fx-mir family members
modulate the translation rate of batteries of mRNAs that are critical
to shift SCs from a proliferative to differentiated cell state.
The human FX-MIR cluster largely shares the expression pattern
of the mouse Fx-mir cluster
We next turned our attention to the human FX-MIR cluster. To
assess its expression characteristics, we examined the levels of 20
mature miRNAs derived from this cluster in human tissues. We
found that all 20 of these human FX-MIR miRNAs are highly
◀ Figure 4. Fx-mir miRNAs target translation regulatory factors.A Fx-mir miRNAs repress FMRP function. Top, Western blot analysis of P19 cells transfected with a pool of Fx-mir miRNAs targeting Fmr1 (miR-743b-3p, miR-878, and
miR-880-3p) and/or a Fmr1 expression vector. Bottom, quantification of the Western blot.
B miR-743b-3p reduces protein synthesis. Left, P19 cells were transfected with negative-control miRNAs or the indicated Fx-mir miRNAs 42 h prior to the addition of
puromycin in the culture medium. The blot was probed with an antibody to puromycin (which detects newly synthesized proteins) and subsequently stained with
Coomassie Blue to control for loading. Right, quantification of puromycin incorporation.
C FMRP, eIF4E, and CYFIP1 interact in the testis. Immunoprecipitation of testis lysates with eIF4E or IgG control antibody, followed by Western blot analysis with the
indicated antibodies. The testis lysate was incubated with RNase A to exclude RNA-dependent protein–protein interactions. The input sample is the whole testes
lysate (5% relative to volume used for immunoprecipitation).
D, E Fx-mir miRNAs target the translation factors eIF4E and CYFIP1. Luciferase analysis of MSC1 cells co-transfected with the pMIR-luciferase reporter harboring the
indicated full-length 30UTR and the indicated Fx-mir miRNAs. miR-741-3p was used to demonstrate specificity for regulation of Eif4e, as this miRNA does not have
a predicted binding site in Eif4e 30UTR. Likewise, miR-741-3p and miR-878 were used to demonstrate specificity for Cyfip1, as these miRNAs do not have binding
sites in the Cyfip1 30UTR. The luciferase activity of cells transfected with a negative-control scrambled precursor is set to 1. A Renilla luciferase vector was co-
transfected to normalize for transfection efficiency.
F, G Mutagenesis analysis demonstrates that Eif4e and Cyfip1 mRNA are Fx-mir direct targets. Luciferase analysis of MSC1 cells co-transfected with (i) a miRNA
precursor or a negative-control scrambled miRNA precursor and (ii) the pMIR-luciferase reporter harboring the wild-type version of the mouse Eif4e and Cyfip1
30UTR or mutant versions with the indicated predicted miRNA-binding site (bs) mutations. The seed sequences are depicted in red and the mutations are in blue. A
Renilla luciferase vector was co-transfected to normalize for transfection efficiency.
Data information: In (A, B, and D–G), the bars in the histogram represent three independent biological replicates. Data are presented as mean  SEM. *P < 0.05
(Student’s t-test).
Source data are available online for this figure.
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expressed in the testis (Fig 5A), just as we showed was the case for
mouse and rat Fx-mir miRNAs (Figs 3A and EV4A). However, the
human FX-MIR cluster differs from the mouse Fx-mir cluster in being
expressed in other adult tissues (Fig 5A). miRNAs expressed from
the 50 region of the FX-MIR cluster tend to be expressed in ovary,
while miRNAs expressed from the 30 region tend to be expressed in
brain and heart. Both 50 and 30 miRNAs are expressed in kidney.
Together, this indicates that while high testis expression is a
conserved feature of the Fx-mir cluster, the human version of this
cluster has diversified its expression, including the brain, where
FMR1 is highly expressed [57].
Given that mouse Fx-mir miRNAs are expressed in SCs (Fig 3B
and C), we assessed whether this might also be the case for human
FX-MIR miRNAs. Toward this end, we obtained RNA from Sertoli
cell-only (SCO) patients, who largely or completely lack germ cells
in their seminiferous tubules. If human FX-MIR family members are
expressed in SCs, their expression relative to total testis RNA would
be expected to be higher in SCO testes than in normal testes. Consis-
tent with this, we found that 6 of the 7 FX-MIR family members we
tested exhibited elevated (~2- to 6-fold) expression in SCO testes as
compared to normal testes (Fig 5B). As a positive control, we tested
the expression of SC markers (FSHR, AMH, SOX9) and found they
were also upregulated in SCO testes (Fig EV5E). These data strongly
suggest that FX-MIR miRNAs are most prominently expressed in SCs
and/or other somatic cells in the human testis.
Given that some human FX-MIR family members are modestly
expressed in brain (Fig 5A), this raised the possibility that the FX-
MIR cluster has a role in FXS. Because the FX-MIR cluster is directly
adjacent to FMR1, the latter of which is methylated and transcrip-
tionally inactivated in neurons in FXS [72], this raised the possibility
that the inactive chromatin at the FMR1 locus has spread to the FX-
MIR cluster and thereby repressed the expression of its miRNAs in
FXS. To test this hypothesis, we used NanoString Technology to
assay the expression of the FX-MIR miRNAs in neuronal progenitor
cells (NPCs) and differentiated neurons derived from iPSC lines
generated from FXS patients and control individuals. This analysis
showed that several FX-MIR miRNAs had significantly dysregulated
expression in FXS NPCs and neurons (Fig 5C and D, and
Appendix Table S3). However, the expression of the FX-MIR cluster
was not broadly repressed, strongly suggesting that the inactive
chromatin from the FMR1 locus had not spread to the FX-MIR clus-
ter. Indeed, two FX-MIR miRNAs (miR-509-3p and miR-890) had
significantly elevated expression in FXS NPCs relative to control
NPCs. A similar trend of regulation was seen in neurons where FX-
MIR family members were both downregulated and upregulated. As
observed in NPCs, neurons upregulated miR-509-3p and miR-890
(by ~78-fold and ~106-fold, respectively). The finding that a subset
of FX-MIR miRNAs are dysregulated in FXS raises the interesting
possibility that these particular miRNAs have a role in FXS.
The human FX-MIR cluster targets FMR1
As described above, the sequences of the miRNAs in the human FX-
MIR cluster and mouse Fx-mir cluster are extremely divergent, such
that only one clear miRNA ortholog can be discerned (Appendix Fig
S1B). This presented an opportunity to ask a unique question—has
the FX-MIR cluster retained the ability to target translation regula-
tory factors despite the rapid divergence in the sequence of the
miRNAs it encodes? As a first step to assess whether members of
the human FX-MIR cluster target FMR1, we screened the 2,588
candidate human miRNAs available in miRBase for their ability to
target FMR1 using the miRNA target prediction programs, micro-
RNA.org and TargetScan. This revealed that 2 of the 15 human
miRNAs exhibiting the highest prediction scores for targeting FMR1
are encoded by the human FX-MIR cluster (Appendix Table S1). In
total, FMR1 is predicted to be targeted by 13 human FX-MIR miRNAs
(microRNA.org), six of which are high-confidence targets with
strong prediction scores (both microRNA.org and TargetScan), and
multiple predicted binding sites (Fig 5E, Table EV4). The total
number of predicted FX-MIR miRNA-binding sites in the FMR1
30UTR is 26.
To experimentally test the validity of this computational analysis,
we cloned the full-length human FMR1 30UTR into a luciferase
reporter vector and tested the activity of three human FX-MIR family
members. We found that two of them—miR-513a-3p and miR-891b—
elicited statistically significant repression in luciferase expression
from the reporter vector harboring the human FMR1 30UTR (Fig 5F).
The third miRNA, miR-888, triggered a trend toward reduced expres-
sion but was not statistically significant. Together with our computa-
tional analysis, the data indicate that the FX-MIR cluster has retained
its ability to regulate FMR1 despite its rapid evolution.
As detailed above, we obtained several lines of evidence that the
Fragile-X gene—Fmr1—is a strongly favored target of miRNAs
encoded by the mouse Fx-mir cluster. To assess whether the same is
the case for the human FX-MIR cluster, we first examined three
genes (SOX9, FSHR, and GJA1) known to be highly expressed in
human SCs [73–75], the main cell type that expresses several FX-
MIR family members (Fig 5B). As shown in Table EV5, the mRNA
encoded by these three SC-expressed genes all had fewer predicted
binding sites for the 24 known FX-MIR family members than did
FMR1 (Table EV5). We also examined the top 20 genes enriched for
expression in human neonatal SCs, as defined by single-cell RNAseq
analysis (Song et al, manuscript in preparation), and found that
most of the mRNAs from these genes had far fewer predicted FX-
MIR family member-binding sites than did FMR1 mRNA
(Table EV5). The only exception—CALD1—had 12 predicted FX-
MIR-binding sites, the same number as for FMR1. Together, these
data support the notion that, like the mouse Fx-mir cluster, the
human FX-MIR cluster has a predilection for targeting FMR1.
Discussion
In this study, we report that the Fragile-X gene, FMR1, is targeted
for repression by a large cohort of miRNAs expressed from a miRNA
cluster adjacent to it. This property appears to be conserved, as we
found that the Fx-mir cluster is directly adjacent to Fmr1 across all
placental mammals we examined. This predilection for targeting
Fmr1 was unexpected given that miRNAs function in trans and thus
have the potential to target virtually any gene in the genome.
Why is Fmr1 a frequent target of a miRNA cluster adjacent to it?
One possibility is that close proximity allows for common regulatory
elements to drive the coordinated expression of Fmr1 and the Fx-mir
cluster, which, in turn, would allow for more efficient regulation.
Consistent with this possibility, Fmr1 and Fx-mir family members
have similar expression patterns. Fmr1 is highly expressed in mouse
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testis, which is also the primary site of Fx-mir expression [48,76,77].
Likewise, in humans, both FMRP and FX-MIR miRNAs are expressed
in the brain and the testis [78]. Also, consistent with the possibility
of common regulatory elements driving their expression, Fmr1 and
the Fx-mir miRNA cluster have a head-to-head configuration. Strik-
ingly, all the miRNAs in both the human FX-MIR and mouse Fx-mir
0
1
2
3
4
5
6
7
8
R
el
at
iv
e
R
N
A
le
ve
ls
mi
R-
88 89
1b
0.0
0.5
1.0
1.5
R
el
at
iv
e
lu
ci
fe
ra
se
un
its
**
miR-507
miR-888-3p
3'
2275 bp
FMR1 3'UTR
5'
miR-513a-3p
miR-888
miR-891b
*
*
**
**
**
**
**
**
miR-890
miR-888
miR-892a
miR-892b
miR-891b
miR-891a
miR-513b
miR-513a-3p
miR-513a
miR-506
miR-507
miR-508-3p
miR-508
miR-509-3
miR-509-3p
miR-509
miR-510
miR-514
FX
-M
IR
**
*
Testis
Ovary
Brain
Liver
Kidney
Heart
miR- 890 8 50
9-3
p
50
9
0
10
20
30
40
50
R
el
at
iv
e 
R
N
A
 le
ve
ls
WT
FXS (848-1)
FXS (848-3)
mi
R-
89
0
mi
R-
89
1b
A B
C E
D F
Figure 5. Expression and function of human FX-MIR miRNAs.
A Heat map depicting the steady-state levels of FX-MIR miRNAs in the indicated adult human tissues, as assessed by TaqMan-qPCR analysis. U6 snRNA levels were used
for normalization.
B FX-MIR miRNAs are enriched in human Sertoli cell-only (SCO) patient samples. Average values from TaqMan-qPCR analysis of testes biopsies from three SCO patients
and three controls. The control values are set as 1. U6 snRNA levels were used for normalization.
C Heat map depicting the relative expression (fold difference) of FX-MIR family members in FXS patient versus healthy control iPSC-derived NPC lines and neurons.
*0.05 < P < 0.1; **P < 0.05.
D Expression of selected human FX-MIR miRNAs in FXS cells. TaqMan-qPCR analysis of human miR-890 and miR-891b in neurons differentiated from iPSC lines
generated from FXS patients and control individuals. The expression level in control cells is set at a value of 1. U6 snRNA levels were used for normalization.
E Location of human FX-MIR-binding sites along the length of the human FMR1 30UTR.
F Evidence that human FX-MIR miRNAs repress human FMR1 expression. Luciferase analysis of HeLa cells co-transfected with the pMIR-luciferase reporter harboring
the human full-length FMR1 30UTR and the indicated FX-MIR miRNAs (n = 3). The luciferase activity of cells transfected with a negative-control scrambled precursor
is set to 1. A Renilla luciferase vector was co-transfected to normalize for transfection efficiency.
Data information: In (B and F), the bars in the histogram represent three independent biological replicates. Data are presented as mean  SEM. *P < 0.05 (Student’s
t-test).
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clusters exhibit the same transcriptional orientation, which is
consistent with the possibility that many or all of them are derived
from a long primary transcript driven by a single promoter. This
architecture allows for a dedicated regulatory domain housing
enhancer elements that can act on both Fmr1 and the Fx-mir cluster.
As precedent for the notion of common regulatory elements driving
non-coding and coding RNAs, Hu et al [79] identified bidirectional
promoters driving the transcription of mRNAs and lncRNAs in oppo-
site directions in neurons. While co-expression of the Fx-mir cluster
and Fmr1 allows the former to regulate the latter in the same cell
types, we suggest that the Fx-mir cluster is also likely to be indepen-
dently regulated from Fmr1. Layering independent regulation on top
of coordinate regulation would allow members of the Fx-mir cluster
to modulate Fmr1 expression in response to specific stimuli.
A non-mutually exclusive explanation for the propensity of the
Fx-mir cluster to target Fmr1 is the Fx-mir cluster originated from an
ancient Fmr1 gene. In support of this possibility, the primordial Fmr1
gene is known to have spawned duplicate copies of itself. Several
autosomal paralogs of Fmr1 currently exist in vertebrate genomes
[80]. We suggest that in addition to dispersing paralogs to other
chromosomes, a primordial Fmr1 gene also generated a duplicated
copy directly adjacent to itself. Duplicated copies of genes often are
generated in tandem arrays through the process of “unequal crossing
over”, a type of gene duplication event that occurs at only low
frequency during mitosis and meiosis, but once it occurs, it can be
selected for over evolutionary time. If Fmr1 was duplicated in this
manner, one copy may have degenerated into an expressed pseudo-
gene that lost its ability to generate a protein and acquired an ability
to generate miRNAs. In favor of this “miRNA birth” hypothesis,
miRNAs have been shown to form relatively easily during short
periods of evolutionary time [18]. An attractive model is the Fx-mir
cluster was derived from a duplicated copy of the Fmr1 gene
transcribed in the antisense direction, as such miRNAs would auto-
matically exhibit a predilection for targeting Fmr1 because they
would be complementary to Fmr1 mRNA. Regardless of the mecha-
nism(s) responsible for Fmr1 and Fx-mir occupying the same
genomic neighborhood, once this genomic arrangement was estab-
lished, it may have been maintained by a mechanism that prevents
genomic rearrangements. Such a rearrangement-suppression mecha-
nism has been postulated to be responsible for Hox-regulatory
miRNAs being retained in Hox gene clusters in multiple species [81].
Indeed, there is evidence that miRNAs tend to exhibit conserved
gene order relative to protein-coding genes [82]. This conservation
may serve to maintain an optimal genomic environment for the
expression and function of miRNAs.
Why does the Fx-mir cluster harbor such a large number of
miRNAs? One possibility is this cluster expanded as a result of selec-
tion to exert strong regulation on Fmr1 and other key target mRNAs.
Single miRNAs typically only downregulate their mRNA targets by
~20–40%, and thus, multiple miRNAs are typically required to
confer stronger regulation [66]. Indeed, we found that combinations
of two Fx-mir family members more strongly repressed Fmr1 30UTR-
driven reporter expression than did single-family members; a combi-
nation of 3 Fx-mir family members conferred particularly strong
(~80%) downregulation. Previous studies have shown that more
pronounced regulation is conferred when miRNA-binding sites are
in close proximity (< 40 nt) [82,83]. Thus, it is of interest that we
observed additive effects of multiple Fx-mir family members even
though their binding sites are relatively far apart in the Fmr1 30UTR
(between 94 and 625 nt apart; see the Results section). The ability
of combinations of Fx-mir miRNAs to strongly regulate Fmr1 expres-
sion raises the possibility that these miRNAs may not only serve as
“fine tuners”, but also serve as biological switches. In particular,
Fmr1 may be a key target that serves in such circuitry, as we found
that Fmr1 30UTR-mediated reporter expression was repressed by
very low doses (0.6 pmol) of some Fx-mir family members (miR-878
and miR-880-3p; data not shown).
A conserved feature of the Fx-mir cluster is its high expression in
the testis. Intriguingly, we obtained evidence that the primary cell
type expressing the Fx-mir cluster in both humans and mice is the
SC, which is a large somatic cell in direct contact with all stages of
developing male germ cells. SCs provide factors and an appropriate
niche that support all steps of spermatogenesis. We found that two
mouse Fx-mir family members, miR-741-3p and miR-880-3p, are
most highly expressed when rodent SCs cease proliferation and
undergo terminal maturation. Thus, these miRNAs are candidates to
regulate the expression of key target mRNAs important for this
proliferation-to-maturation transition phase of Sertoli cell develop-
ment. Two other miRNAs in the mouse Fx-mir cluster, miR-878 and
miR-743b-3p, display highest expression at a slightly later point of
development—P20—when SCs undergo further maturation and the
most advanced germ cells are undergoing the transition from
meiosis to differentiation [79,80]. Other members of the Fx-mir clus-
ter, including miR-743a-3p and miR-883a, have been shown to
display peak expression during this same ~P15 to ~P20 time window
[48], raising the possibility that many miRNAs from the Fx-mir clus-
ter cooperate to drive or fine-tune events that occur during this criti-
cal somatic and germ cell developmental time period.
While rodents primarily express the Fx-mir cluster in the testis,
we found that humans express FX-MIR cluster in other tissues,
including the brain. It has been often noted that many genes are co-
expressed in the testes and the brain, but the evolutionary forces
driving this expression pattern and the functional consequences of it
are not known [84,85]. The expression of the FX-MIR cluster in both
brain and testis in humans is of interest given that its major target,
FMR1, is particularly highly expressed in these two particular
organs, as described above [78,86]. Thus, the FX-MIR cluster may
regulate translation in cells in both of these two organs through its
ability to repress FMRP levels.
The rapid sequence divergence of the X-linked Fx-mir cluster is
consistent with a wide body of work showing that X-linked and
testes-expressed genes tend to undergo rapid evolution [76–80].
Increasing evidence suggests that the testis is birthplace of many
genes and has a permissive environment for gene expression and
therefore has a particularly diverse transcriptome [40,76]. This is
not restricted to protein-coding genes, as studies have shown that
miRNAs in their rapidly evolving phase also commonly exhibit
restricted expression in the testis [81–83]. Indeed, the Fx-mir cluster
appears to be fairly young, which may contribute to its rapid evolu-
tion.
The rapid evolution of the Fx-mir cluster presents an interesting
dilemma. While Fx-mir sequence alterations permit the miRNAs
expressed from this cluster to regulate new target mRNAs, how do
they retain the ability to regulate previous critical mRNA targets?
We suggest that in some cases, miRNAs and their critical targets
undergo co-evolution, such that sequence alterations in the miRNAs
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select for corresponding sequence alterations in the mRNA target to
maintain sequence complementarity. In the case of coordinately
regulated miRNA clusters such as the Fx-mir cluster, a flexible
approach may be used to achieve this goal, such as a “division of
labor” approach in which “old” and “new” mRNA targets are regu-
lated by different family members. In support, we found that many
seemingly unrelated miRNAs in the human and mouse Fx-mir clus-
ters targeted Fmr1, raising the possibility that selective forces acting
on independent miRNAs were responsible for maintaining Fmr1
regulation in the primate and rodent lineages. Thus, in spite of the
rapid divergence of sequence, both the mouse and human Fx-mir
clusters are able to efficiently target Fmr1. Thus, the Fx-mir cluster
may be a useful model to study miRNA clusters at an intermediate
point of evolution that are rapidly acquiring new mRNA targets
(“new friends”) but also maintaining a subset of their old mRNA
targets (“old friends”).
Functional conservation in the face of rapid sequence evolution
is a growing theme in biology. For example, Ulitsky et al identified
lincRNAs that have conserved roles in embryonic development in
zebrafish and humans despite the fact they exhibit little sequence
conservation between these two species [84]. These lincRNAs
maintain their location in the genomes of diverse species, just as
we showed is the case for the rapidly evolving Fx-mir cluster.
Another example of maintenance of function in the face of
sequence diversity is transcription factor cis-regulatory elements,
which have been shown to maintain the ability to regulate specific
genes and transcriptional programs despite undergoing rapid
changes in sequence [85]. Indeed, retention of precise transcription
factor binding sites appears to be the exception, rather than the
rule, over evolutionary time. For example, the Endo16 promoter,
while divergent in sequence in two sea urchin species, Strongylo-
centrotus purpuratus and Lytechinus variegatus, maintains its tran-
scription pattern during larval development in these two species
[86]. Similarly, the enhancer elements in the even skipped locus in
Drosophila and scavenger flies are highly divergent in sequence,
yet they drive identical expression patterns in transgenic Drosophila
embryos [87].
In conclusion, we have defined a new miRNA cluster and found
that a large cohort of miRNAs expressed from this cluster target
Fmr1, the gene directly adjacent to it in all placental mammals we
examined. Several members of the Fx-mir cluster target not only
Fmr1, but also mRNAs encoding other proteins that form a regula-
tory complex with FMRP. This result, coupled with our finding that
many members of the FX-MIR cluster are expressed in human
neurons and SCs, raises the possibility that one function of this
miRNA cluster is to control the translation of batteries of mRNAs in
these seemingly unrelated somatic cells. In the future, it will be
important to determine the clinical consequences of dysregulated
FX-MIR expression.
Materials and Methods
Mammalian cell culture, transfections, and luciferase assays
MSC1 and HeLa cells were grown in DMEM (Invitrogen), 10% fetal
calf serum, and 1× penicillin/streptomycin. P19 cells were grown in
MEMa (Invitrogen), 10% fetal calf serum, and 1× penicillin/
streptomycin (Invitrogen). All cells were cultured at 37°C with 5%
CO2. For transfection experiments, the cells were trypsinized and
seeded in 24-well plates at a density of ~50,000 cells per well. The
cells were transiently transfected using Lipofectamine 2000 (Invitro-
gen), following the manufacturer’s instructions. The transfections
were carried out with 20 pmol of miRNA precursor, 20 ng of firefly
luciferase vector, and 10 ng of the Renilla luciferase vector. Dual
luciferase analysis (using a Renilla Luciferase vector for normaliza-
tion) was performed according to the manufacturer’s instructions
(Promega, Cat. no. E1960) on lysates prepared 24 h post-transfec-
tion. Statistical significance was determined using the paired
Student’s t-test.
Testis cell fractionation
Sertoli and interstitial cells were purified from testes as previously
described [41]. In brief, testes were decapsulated and the seminifer-
ous tubules were allowed to settle in PBS, followed by incubation in
collagenase (C2674; Sigma). After another round of settling, the
pellet and supernatant were used as the source of SCs and intersti-
tial (mainly Leydig) cells, respectively. To obtain enriched SCs, the
pellet was resuspended in a solution containing 0.1% collagenase,
0.2% hyaluronidase (H6254; Sigma), 0.04% DNase I (D5025;
Sigma), and 0.03% trypsin inhibitor (T6522; Sigma) in 1× PBS (pH
7.4) at 30°C for 40 min. The SCs were purged of contaminating
germ cell by hypotonic shock (incubation in 1:7 diluted PBS for
3 min). To obtain enriched Leydig cells, the supernatant obtained
after collagenase treatment was pelleted and subjected to the same
hypotonic shock treatment as the SCs.
30UTR cloning
The full-length 30UTR of Fmr1, Eif4e, and Cyfip1 were PCR-amplified
from mouse and/or human testis cDNA, and then cloned into pMIR-
REPORT vector, which lacks a 30UTR (Ambion, Cat. no. AM5795).
Site-directed mutagenesis
Site-specific mutagenesis was performed, as previously described
[87], to generate the mutant versions of the 30UTR reporter vectors.
The primers used to generate the mutants are provided in
Appendix Table S4.
miRNA quantification
Total cellular RNA was isolated from cells and tissues using
TRIzol (Invitrogen). TaqMan-qPCR was performed (in triplicate
for each sample) using TaqMan microRNA assays (Applied
Biosystems).
Real-time PCR analysis
Total cellular RNA was isolated using TRIzol (Invitrogen), as
previously described [27]. Reverse transcription–PCR analysis was
performed by first generating cDNA from 1 lg of total cellular
RNA using iSCRIPT (Bio-Rad), followed by PCR amplification using
SYBR Green and the DDCt method (with ribosomal L19 for
normalization).
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Protein analysis
For Western blot analysis, cells were harvested in radioimmunopre-
cipitation assay (RIPA) buffer supplemented with protease inhibitor
cocktail (Sigma, Cat. no. P8340) and phenylmethylsulfonylfluoride
(PMSF). Following incubation in lysis buffer on ice for 30 min, the
samples were centrifuged at 16,050 g for 15 min at 4°C, and the
lysates were transferred to new tubes, and protein level was quanti-
fied using the DCTM Protein Assay kit (Bio-Rad, Cat. no. 500-0112).
Twenty micrograms of the protein samples was separated on an 8–
12% polyacrylamide gel, and Western blot analysis was performed
as previously described [41].
For anti-puromycin detection of newly synthesized proteins, the
image from gel electrophoresis was captured and the membrane
was stained with Coomassie Blue to verify equal loading in all lanes.
Densitometric measurements were performed by determining the
density of each whole lane (incorporating the entire molecular
weight range of puromycin-labeled proteins) using ImageJ software
(U.S. National Institutes of Health, Bethesda, MD, USA; https://
imagej.nih.gov/ij/). Details of the antibodies used are provided in
Appendix Table S5.
Protein synthesis was also measured using the L-azidohomoalanine
(AHA) Click-iT (Thermo Fisher Scientific, C10102) metabolic label-
ing reagents, following the manufacturer’s protocol. Briefly,
cultured P19 cells were washed twice with warmed PBS and incu-
bated in methionine-free DMEM (Thermo Fisher Scientific,
21013024) for 1 h. The medium was replaced with methionine-free
DMEM to which 50 lM of the methionine analog AHA was added.
After incubation, the dishes were rinsed twice. Newly synthesized
proteins labeled with Click-iT AHA were conjugated with the
tetramethylrhodamine alkyne (TAMRA) using the Click-iTTM
Tetramethylrhodamine (TAMRA) Protein Analysis Detection Kit
(Thermo Fisher Scientific, C33370). Protein samples were sepa-
rated on 10% SDS–PAGE and visualized using 532 nm excitation.
The gel was subsequently stained with Coomassie blue for normal-
ization.
Immunoprecipitation analysis
Testis from 1-month-old BL6 mice were harvested, decapsulated,
and immediately put into 400 ll of ice-cold lysis buffer (10 mM
Tris–HCl pH 7.5, 10 mM NaCl, 2 mM EDTA) supplemented with
PMSF, protease inhibitor cocktail, and phosphatase inhibitor cock-
tail (Phosphatase Arrest I, G-Biosciences, Cat. no. 786-450). The
decapsulated testes were crushed with a pestle and incubated, with
intermittent inversion, in the lysis buffer for 15 min on ice. NaCl
was then added to all the samples at a final concentration of
150 mM, and the indicated samples were treated with 5 ll of RNase
A (10 mg/ml). The tubes were inverted and subjected to gentle
vortex before 10 min of incubation on ice. The lysates were then
spun at maximum speed for 15 min at 4°C, and the supernatant was
used for IP analysis. Protein G sepharose beads (Invitrogen, Inc.)
were prepared for IP analysis by washing them twice with NET-2
buffer (50 mM Tris–HCl pH 7.5, 150 mM NaCl, 0.05% Triton-X
100). 40 ll of a 100 mg/ml bead slurry was incubated with 5 ll of
either eIF4E polyclonal antibody or purified rabbit IgG (5 lg) resus-
pended in NET-2 buffer supplemented with PMSF, protease inhibitor,
and phosphatase arrest and incubated overnight at 4°C. The
antibody-coupled beads were washed three times with NET-2 buffer
with gentle centrifugation inbetween (250 g for 1 min). The washed
antibody-coupled beads were left on ice until the testis lysates were
ready to be incubated. Testes lysates (400 ll), prepared as described
above, were incubated for 2–4 h on ice. The beads were then
washed eight times with NET-2 buffer with gentle centrifugation
inbetween. After the last wash, most of the supernatant was
removed, 10 ll of SDS–polyacrylamide gel electrophoresis (PAGE)
loading buffer was added, the beads were vortexed, boiled for
5 min, vortexed again, centrifuged at maximum speed (13,000 g),
and the supernatant was loaded on a 12% polyacrylamide gel for
Western blot analysis.
Control and Fragile-X Syndrome neural progenitor and
differentiated neuron preparation
Fibroblasts from a clinically healthy male control (GM08330) or a
diagnosed Fragile-X Syndrome male patient (GM05848) were
purchased from Coriell Institute for Medical Research and used to
derive induced pluripotent stem cell (iPSC) clones and subsequent
stable, homogeneous neural progenitor cells (NPCs) as described
[88]. NPCs were expanded in 70% DMEM (Invitrogen), 30% Ham’s
F-12 (Mediatech), supplemented with B-27 (Invitrogen), 20 ng/ml
EGF (Sigma), and 20 ng/ml bFGF (R&D Systems) on poly-ornithine
(Sigma)/laminin (Sigma)-coated culture plates. Neural differentia-
tion was induced by growth factor removal in the same media for
15 days before harvest. Cells were harvested by scraping and pellet-
ing followed by total RNA (including miRNAs) isolation using a
miRNeasy Mini Kit (Qiagen). Biological triplicates were collected
from each undifferentiated NPC and differentiated neuron cultures
from control 8330-8 and two clones from the FXS patient: 848-1 and
848-3 [88].
NanoString nCounter miRNA profile analysis
miRNAs were processed with the NanoString nCounter system
(NanoString, Seattle, Washington, USA) per vendor instructions
with chipsets of Human miRNA v.1 (664 endogenous miRNAs and
five housekeeping transcripts). Data archiving, normalization, anal-
ysis, and file export were performed using nSolver software v.2.5
(NanoString). Probe intensity data between samples were normal-
ized using nSolver Software utilizing either the geometric means of
five housekeeping genes (ACTB, B2M, GAPDH, RPL19, and
RPLP0) or geometric mean normalization of the highest 100 values
within each sample. For the purpose of comparison, control
samples (n = 3 from each condition) were compared to combined
FXS samples from both 848-1 and 848-3 (thus n = 6 from each
condition).
Expanded View for this article is available online.
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